On Monday, Sagimet Biosciences Inc (NASDAQ: SGMT) opened lower -7.51% from the last session, before settling in for the closing price of $5.99. Price fluctuations for SGMT have ranged from $1.73 to $11.41 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -16.85%. Company’s average yearly earnings per share was noted -16.36% at the time writing. With a float of $26.33 million, this company’s outstanding shares have now reached $31.00 million.
Sagimet Biosciences Inc (SGMT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sagimet Biosciences Inc is 19.03%, while institutional ownership is 32.77%. The most recent insider transaction that took place on Nov 20 ’25, was worth 289,979. In this transaction Executive Chairman of this company sold 37,688 shares at a rate of $7.69, taking the stock ownership to the 81,005 shares. Before that another transaction happened on Nov 20 ’25, when Company’s Director proposed sale 37,688 for $7.85, making the entire transaction worth $295,851.
Sagimet Biosciences Inc (SGMT) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.5 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.59) by 0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -16.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.25% during the next five years compared to -16.85% drop over the previous five years of trading.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
Looking closely at Sagimet Biosciences Inc (NASDAQ: SGMT), its last 5-days average volume was 0.38 million, which is a drop from its year-to-date volume of 0.56 million. As of the previous 9 days, the stock’s Stochastic %D was 18.43%.
During the past 100 days, Sagimet Biosciences Inc’s (SGMT) raw stochastic average was set at 0.88%, which indicates a significant decrease from 2.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.35 in the past 14 days, which was lower than the 0.51 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.02, while its 200-day Moving Average is $6.41. However, in the short run, Sagimet Biosciences Inc’s stock first resistance to watch stands at $5.90. Second resistance stands at $6.27. The third major resistance level sits at $6.47. If the price goes on to break the first support level at $5.34, it is likely to go to the next support level at $5.14. Should the price break the second support level, the third support level stands at $4.77.
Sagimet Biosciences Inc (NASDAQ: SGMT) Key Stats
There are currently 32,522K shares outstanding in the company with a market cap of 171.75 million. Presently, the company’s annual sales total 0 K according to its annual income of -45,570 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -12,910 K.
